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Plasmids are the workhorse of both industrial biotechnology and synthetic biology, but ensuring
they remain in bacterial cells is a challenge. Antibiotic selection cannot be used to stabilize plasmids
in most real-world applications, and inserting dynamical gene networks into the genome remains
challenging. Plasmids have evolved several mechanisms for stability, one of which, post-segrega-
tional killing (PSK), ensures that plasmid-free cells do not survive. Here we demonstrate the
plasmid-stabilizing capabilities of the axe/txe toxin-antitoxin system and the microcin-V bacteriocin
system in the probiotic bacteria Escherichia coli Nissle 1917 and show that they can outperform the
commonly used hok/sok. Using plasmid stability assays, automated flow cytometry analysis, math-
ematical models, and Bayesian statistics we quantified plasmid stability in vitro. Furthermore, we
used an in vivo mouse cancer model to demonstrate plasmid stability in a real-world therapeutic
setting. These new PSK systems, plus the developed Bayesian methodology, will have wide applica-
bility in clinical and industrial biotechnology.
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The genes comprising a synthetic circuit can be maintained in a host bacterium in two ways: on the chro-
mosome of the organism or on extra-chromosomal material such as plasmids. Plasmids are a funda-
mental biological tool and have been widely used in molecular and cellular biology research, leading
to a number of well-developed methods for their manipulation (Ellis et al., 2011; Casini et al., 2015).
This ease of manipulation enables a level of modularity, which is one of the key engineering goals of syn-
thetic biology (Andrianantoandro et al., 2006; Martinez-Garcia et al., 2014). Plasmid copy number can be
an important parameter in the functioning of circuits, and it is non-trivial to convert a dynamical gene
circuit from a multi-copy plasmid implementation to a single-copy implementation and maintain iden-
tical function (Lee et al., 2016).
However, one of the fundamental problems with using plasmids is their segregational instability. When
bacteria divide there is the possibility that all plasmid copies remain in one-half of the cell, which leads
to the production of a plasmid-free daughter cell, as shown in Figure 1A. As most of the synthetic circuits
that are borne on plasmids produce a burden to their hosts, the plasmid-free population outgrows the
plasmid-bearing population and the engineered strain is quickly diluted from the environment (Summers,
1991). Maintaining the presence of the engineered circuit within the bacterial population is fundamentally
important in the design of a predictable synthetic biological system.
Antibiotic selection of bacteria-containing plasmids with the corresponding antibiotic resistance genes is
commonly used in a research environment. However, antibiotics are not used in industrial fermentation
because of the financial impact of removal and deactivation (Kroll et al., 2010). Antibiotics are also unsuit-
able for clinical applications for a number of reasons including horizontal gene transfer of resistance genes
(Stecher et al., 2012; Wright et al., 2008) and the disruption of the native microbiota (Theriot et al., 2014). In
light of these limitations, efforts have already been made to reuse a variety of existing microbial mecha-
nisms to ensure plasmid persistence in more complex environments (Kroll et al., 2010; Wright et al.,
2013). Successful alternatives have been demonstrated with the use of toxin-antitoxin (TA) systems (Loh
and Proft, 2013; Danino et al., 2015), active partitioning mechanisms (Danino et al., 2015; Liu et al.,
2005), and auxotrophy (Velur Selvamani et al., 2014a, 2014b).iScience--, 1–12,--, 2019 ª 2019 The Authors.




Figure 1. Plasmid Stability and Post-segregational Killing
(A) Plasmid-free cells are produced due to uneven distribution of plasmids at cell division.
(B) Toxin-antitoxin PSK systems are plasmid-borne mechanisms. (C) These systems rely on a long-lived toxin degrading
more slowly in a newly plasmid-free cell than the antitoxin.
(D) Post-segregational killing mechanisms carried on plasmids cause the death of cells that lose the plasmid when
dividing.
(E) Bacteriocins can improve plasmid stability by a population-level policing through the secretion of a toxin into the
environment.
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of a long-lasting toxin and its shorter-lived antitoxin (Cataudella et al., 2012; Diago-Navarro et al., 2013),
both encoded on the plasmid (Figures 1B and 1C). While the plasmid is present in the cell, antitoxin is being
produced to neutralize the toxin. If, however, a plasmid-free daughter cell arises, the antitoxin quickly de-
grades and is unable to be replaced due to lack of the necessary genes. The negative effects of the toxin are
no longer prevented, leading to the killing or growth prevention of the cell (Figure 1D). The successful PSK
of a plasmid-free cell is reliant on enough toxin becoming active in the cell before it goes on to divide again,
further diluting the toxin. Just as with the distribution of plasmids giving a probability of producing
plasmid-free cells, there is a probability that the distribution of toxin is such that the TA system fails to
kill the newly plasmid-free cell. As such, TA systems are fallible, and once plasmid-free cells escape,
they have no mechanism for preventing their growth and the consequent dilution of the plasmid-bearing
population. hok/sok is a type I TA system originating from the parB locus of the E. coli plasmid R1 and has
been shown to be effective in its native E. coli and the gram-negative Pseudomonas putida (Gerdes, 1988).
axe/txe is a proteic, type II TA system originating from the axe-txe locus of the gram-positive Enterococcus
faecium plasmid pRUM (Grady and Hayes, 2003). It has been demonstrated that axe/txe could be used
to stabilize a luminescent reporter in the gram-positive Enterococcus faecalis in vivo without antibiotic
selection for 5 days (Rosa et al., 2013). The axe/txe system was also found to be present in 75% of
vancomycin-resistant enterococci isolates, a common hospital pathogen and growing global concern
(Moritz and Hergenrother, 2007).
An alternative to TA systems are bacteriocins, which are bacterially secreted proteins that have a bacteri-
cidal effect on either a narrow or broad spectrum of other bacteria lacking immunity (Riley, 1998). By
secreting these antimicrobial peptides, a plasmid-bearing population is able to police the environment,
preventing the growth of plasmid-free cells (depicted in Figure 1E). Successful attempts have already
been made to use bacteriocins, such as the Lcn972 system, to stabilize plasmids in Lactococcus lactis
(Campelo et al., 2014) and the colicins A and E2 in E. coli (Inglis et al., 2013). Here we use the microcin-V
system, which is encoded on conjugative plasmids in E. coli. It consists of a low-molecular-weight toxic
bacteriocin, which kills through pore formation, along with the genes for an ABC transporter and immunity
protein (Azpiroz and Lavin˜a, 2007). Microcin-V does not undergo any post-translational modification and,
as such, does not require any additional enzyme-encoding genes. The structure of the bacteriocin gene2 iScience--, 1–12,--, 2019
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other bacterial strains (Acun˜a et al., 2012, 2015). Furthermore, it has been shown that E. coli Nissle (EcN)
already carries two bacteriocin systems in its chromosome, microcins H47 and M (Grozdanov et al.,
2004). More recently, it was also shown that native bacteriocins found in EcNwere vital in mediating compe-
tition in the inflamed gut in an inter- and intraspecies manner (Sassone-Corsi et al., 2016).
In this work we develop a mathematical model that describes how PSK systems improve plasmid mainte-
nance. Using several origins of replication, we show how plasmid copy number and burden affect plasmid
stability, with and without a TA system. We use our mathematical model and develop a Bayesian inference
procedure to quantify the efficacy of two PSK systems, axe/txe and microcin-V, in stabilizing a burdensome
plasmid in EcN and compare them to the more commonly used hok/sok system. The model enables deter-
mination of PSK efficacy and also the extra metabolic burden due to the PSK system. We show that the
bacteriocin, unlike the TA systems, is able to remove plasmid-free bacteria from an environment if they
arise. We also investigate the ability of the PSK systems in stabilizing a luminescent reporter plasmid
without antibiotic selection in vitro and in a mouse tumor xenograft model in vivo. Collectively, we show
that the two new systems show a much greater potential for plasmid stabilization than hok/sok in EcN.RESULTS
A Mathematical Model for Plasmid Loss and Post-segregational Killing
Early mathematical models of plasmid stability consisted of terms for a plasmid-bearing population and
plasmid-free population, growing exponentially at different rates with a constant probability of plasmid
loss from the plasmid-bearing population (Boe et al., 1987). These models were used to determine plasmid
loss rates from experimental data (Boe, 1996; Boe and Rasmussen, 1996) and extended to describe bacte-
rial populations in a chemostat, introducing dilution as well as growth rates dependent on a substrate
(Ganusov and Brilkov, 2002). A more detailed model of plasmid loss was devised that takes into
account the age distribution of bacteria within a population, although the predictions produced were
virtually indistinguishable from simpler models (Lau et al., 2013). However, this model did highlight the dif-
ficulties of trying to infer the plasmid loss rate from measured population data as, due to the exceedingly
small plasmid loss rates of most systems, the growth rate differences dominate the dynamics and lead to
overestimation of plasmid loss (Lau et al., 2013).
Here, we extend the early plasmid loss model (Boe, 1996) to include PSK by a TA system. In this model there
are two populations, plasmid-bearing (X+) and plasmid-free (X) populations
dX +
dt
=gX +  lgX +
dXdt
=X + lgX +  ulgX + (Equation 1)
where l is the probability of producing a plasmid-free daughter cell when a plasmid-bearing cell divides, g
is the ratio of plasmid-free doubling time to plasmid-bearing doubling time, and u is the probability of suc-
cessful PSK. The time step, t, is equal to one plasmid-free generation.
Bacteriocins do not produce PSK in the traditional sense. Instead there is a constant killing pressure on the
plasmid-free population rather than specific killing of newly plasmid free cells. As such, the equation for the
change in plasmid-free population differs to take into account the different point at which the bacteriocin
causes the death of plasmid-free cells.
dX
dt
=X + lgX +  2uX (Equation 2)
Figure S1 shows the effects of varying each of the model parameters on the dynamics of plasmid loss.
The plasmid loss parameter, l, which is related to average plasmid copy number, n, according to
l = 21n (Summers, 1991), affects the gradient of the plasmid loss curves early on, when there are very
few plasmid-free cells. As soon as a plasmid-free population is established, the doubling time ratio, g,
which is a measure of the burden placed on the cell by the plasmid, has a large effect on the gradient.
For the TA model in Equation 1, the killing parameter, u, has a similar effect on the parameter l. This is
because it acts to delay the establishment of a plasmid-free population. The killing parameter in the bacte-
riocin model produces different dynamics to that for the TA model as it acts on all plasmid-free cells ratheriScience--, 1–12,--, 2019 3
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parameters to be determined from simulated and experimental plasmid loss curves (Transparent Methods,
Figure S2).
Plasmid Copy Number and Burden Affect Plasmid Stability
A series of fluorescent reporter plasmids, expressing dasher GFP from the strong constitutive OXB20 pro-
moter, were produced with four different origins of replication (Figure 2A), which would offer a range of
plasmid copy numbers (Jahn et al., 2016). The SC101 origin, without native active partitioning system, pro-
vided a low plasmid copy number; p15A, a medium copy number; ColE1, a high copy number; and pUC, a
very high copy number. Quantitative PCR (qPCR) was carried out to determine the copy number of these
plasmids within EcN-Lux. Primers for plasmid amplification were chosen within the kanamycin resistance
gene. This region is common across all the plasmids we used, negating the need to design primers for
each plasmid. The qPCR results (Figure 2B) show that the SC101 origin does, indeed, produce the lowest
plasmid copy number (4.8). The p15A origin has a slightly higher copy number (12), and the hybrid
ColE1-RO1600 origin has an even higher copy number (21). However, the pUC origin is far from the
very high copy number that has been reported in the literature previously (Yanisch-Perron et al., 1985)
and is comparable with the p15A origin (14.5). Furthermore, the variance in copy number for the hybrid
ColE1-RO1600 is large, with the highest copy replicate roughly four times higher than the median. These
plasmid copy numbers are broadly in agreement with other recent estimates (Jahn et al., 2016).
Using a microplate reader to collect growth data and a non-parametric Gaussian process method to fit the
growth curves (Swain et al., 2016), we were able to quantify the effect of carrying plasmids with different
replication origins. The growth curves and model fits from which the maximal growth rates are estimated
are shown in Figure S3. Growth rate measurements for each of the plasmids in EcN-Lux mirror the plasmid
copy numbers measured using qPCR; the low copy SC101 plasmid has the lowest impact on growth rate,
whereas the highest copy ColE1-RO1600 origin produces the greatest burden (Figure 2C). These results
demonstrate the problem for plasmid stability; once the plasmid is dropped, the significantly higher
growth in the plasmid-free strain causes the plasmid-bearing population to be outcompeted.
A daily passaging method was used to gather flow cytometry data, which was analyzed using an automated
analysis pipeline (Transparent Methods, Figures S4–S11). This allowed us to determine plasmid stability over
21 days for the strains bearing plasmids with each of the four different replication origins, with and without
the hok/sok TA system (Figure 2D). Our results are contrary to the conventional wisdom that a lower copy num-
ber plasmidwill be lost sooner. Herewe show that, in fact, the higher copynumber plasmids, ColE1-RO1600 and
pUCare lost sooner than the lowest copy SC101-basedplasmid. This pattern is also reflectedwhen the plasmids
carry the hok/sok TA system. However, the p15A-based plasmid with the hok/sok system performs best,
suggesting that there may be an optimum plasmid copy number for such TA systems.
Toxin-Antitoxin Systems Minimally Impact Growth Rates
The pUC-based fluorescence reporter plasmid was used to determine the efficacy of three different
plasmid-stability mechanisms: hok/sok, axe/txe, and microcin-V (Figure 3A). This plasmid was chosen as,
from the above results, it resulted in the fastest plasmid loss of the four replication origins tested. qPCR
was again used to determine the effect on plasmid copy number of carrying the different plasmid stability
mechanisms (Figure 3B). This showed no difference between the control plasmid and the hok/sok-carrying
plasmid. However, the axe/txe system shows a slight, but insignificant, increase in copy number, whereas
the bacteriocin system shows a slight decrease in copy number.
Growth rates were assayed, and themaximal growth rates were determined (Figure 3C). The growth curves and
model fits from which the maximum growth rates are estimated are shown in Figure S12. The maximal growth
rates show a significant load on the growth rate between plasmid-free EcN-Lux and the plasmid-bearing strains.
The TA systems have similar growth rates to the pUC-GFP control plasmid, repeating the pattern of plasmid
copy number as an indicator of growth rate. However, the bacteriocin system, even with the slightly lower
copy number measured from qPCR, has a slower growth rate than the other plasmids.
Both axe/txe and Microcin-V Outperform hok/sok in Liquid Culture
Flow cytometry data (Figures S13–S16) were gathered using our daily passaging method and were used to




Figure 2. Plasmid Origin of Replication Affects Segregational Stability
(A) Plasmids with different origins of replication were produced, constitutively expressing GFP.
(B) Using qPCR, average plasmid copy number was calculated for each of the origins of replication. (Circles show samples,
red circles are considered outliers.)
(C) Changes in bacterial growth rate correspond to differences in plasmid copy number, with the higher-copy plasmids
producing a larger reduction in maximal growth rate. (Filled circles show the mean calculated maximal growth rates, and
lines show standard deviations.)
(D) The effects of plasmid copy number and growth rate, dictated by the origin of replication, combine to alter the
segregational stability of the different plasmids over 3 weeks of passaging. Although the commonly used hok/sok toxin-
antitoxin system is able to increase stability, none of the plasmids are perfectly maintained over 20 days. (Black circles
show outliers.)
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12 passages. Figures 3D and S17 show that the TA systems improve the stability of the plasmid, although




Figure 3. Plasmid Stability Mechanisms Have Varying Efficacy
(A) Two toxin-antitoxin and one bacteriocin mechanism were cloned into the pUC-based burdensome plasmid and transformed into EcN-Lux.
(B) qPCR shows that the two toxin-antitoxin systems have minimal effect on plasmid copy number. The bacteriocin system, however, seems to reduce copy
number slightly. (Circles show samples, red circles are considered outliers.)
(C) Maximal growth rates show that the burden of carrying the toxin-antitoxin systems does not affect growth. However, even with a lower copy number, the
bacteriocin system shows a reduced maximal growth rate. (Filled circles show the mean calculated maximal growth rates, and lines show standard
deviations.)
(D) Plasmid loss curves for fluorescence-based plasmids in EcN-Lux. The gray lines show the trajectories of nine replicates for each strain. The solid red line
shows the average model fit, and the dashed red lines show the 95% confidence intervals of the model with posteriors from all replicates.
(E) qPCR carried out before undergoing passaging, after 30 days of passaging, and after 30 days of passaging with plasmid maintenance enforced by
antibiotic selection. These back up the plasmid loss seen in the curves calculated from flow cytometry data (D). (Black circles show outliers.)
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the data shows that the hok/sok system has a very high killing efficacy, with a survival probability of less than
53 105 (Figure S18) but still loses out to competition from the few plasmid-free cells that escape the toxin.
Strikingly, axe/txe (EcN-Lux:pUC-GFP-AT) remains stable throughout the experiment, clearly demon-
strating its efficacy over the other systems. As no plasmid loss is observed, the model-fitting procedure
cannot be applied as there is no information on the probability of plasmid loss, l. Finally, the results
demonstrate that the microcin-V system (EcN-Lux:pUC-GFPMCC) outperforms the hok/sok system,
although the results are varied, with four of the nine replicates remaining entirely plasmid bearing for
the length of the experiment and in five of the replicates we see a plasmid-free population taking over.
The model determined that efficiency of the bacteriocin killing is far below that of hok/sok, although,
due to its population-scale effect, it still manages to produce stable populations for a longer period
(Figure S18).
qPCR was carried out to determine how the plasmid copy number had changed, from the initial cultures to
the cultures after 30 passages, in both the selective (erythromycin and kanamycin) and non-selective (only
erythromycin) conditions (Figure 3E). After 30 passages of growth under selective conditions, the plasmid
copy number had slightly increased for all the plasmids. This may be due to the enforced co-existence of
the plasmids in the host leading to compensatory changes within the host or plasmid (Bouma and Lenski,
1988). The raw flow cytometry data show that when plasmid maintenance is enforced through the use of
antibiotics the fluorescence levels remain stable across the full 37 passages for all but the microcin-V-
bearing strain (Figures S13–S16). For the control plasmid and two TA system plasmids, this suggests
that there is compensation between gene expression and copy number, which leads to the overall main-
tenance of fluorescence level. This conclusion is further supported by the population-level fluorescence
data recorded using a microplate reader (Figure S17).
The average plasmid copy number after 30 passages of growth under non-selective conditions reinforces
the results determined using flow cytometry. The control plasmid (EcN-Lux:pUC-GFP) has been
completely lost, with levels comparable to the EcN-Lux strain with no plasmid. The hok/sok-carrying
plasmid (EcN-Lux:pUC-GFP-HS) is similarly low, although there may be a small number of plasmids still
present within the population that have not been removed through passaging. As was seen with the flow
cytometry data, the axe/txe-bearing plasmid is still entirely present, and at levels comparable to the
strains grown in selective media. Finally, the broad spread of copy numbers seen in the microcin-V sys-
tem (EcN-Lux:pUC-GFP-MCC) reflects the heterogeneity seen in the flow cytometry data. Some of the
replicates have completely lost the plasmid, whereas others are at an intermediate stage or are still
plasmid bearing.
Microcin-V Can Restore a Plasmid-Bearing Population
As we have seen with hok/sok, once plasmid-free cells arise in the population the TA system has no way to
save the plasmid-bearing population. Bacteriocins, however, are able to police the entire population due
to the toxin being secreted into the environment. This means that when plasmid-free cells arise or if the
culture becomes contaminated, the bacteriocin system can push the population back toward entirely
plasmid bearing.
Figure 4 shows that when a population of TA plasmid-bearing cells is diluted with plasmid-free EcN-Lux,
the plasmid-free population outgrows the plasmid-bearing population, further diluting it. However,
when we dilute the EcN-Lux:pUC-GFP-MCC cells, they quickly kill the plasmid-free population and restore
the population. In fact, within 24 h there are no plasmid-free cells detectable in all but one anomalous
sample.
Microcin-V Instability Is Due to Immunity Development
As we have shown that the bacteriocin has the ability to kill plasmid-free cells introduced to their environ-
ment (Figure 4), why is there plasmid loss in Figure 3D? Three possibilities are the entire population is still
plasmid bearing but some are no longer GFP expressing, the plasmid-bearing cells are no longer express-
ing the bacteriocin, or plasmid-free cells have developed immunity. To test these possibilities we used the
cultures from the 30th passage of the plasmid loss experiment. These cultures were grown for 6 h with and
without kanamycin selection. The cultures grown non-selectively reflect the state of the population at the
time of being passaged. They were spotted next to a bacteriocin-producing, EcN-Lux:pUC-GFP-MCC,iScience--, 1–12,--, 2019 7
Figure 4. Plasmid-Bearing Strains Are Diluted with Plasmid-Free EcN-Lux at Different Ratios
The dilutions are sampled after 24 h and show that the faster growth rate of the plasmid-free cells leads to further dilution of the plasmid-bearing population.
In the case of EcN-Lux:pUC-GFP-MCC, however, the secreted bacteriocin allows the plasmid-bearing population to outcompete the plasmid-free cells. Blue
points show the median of three replicates at each initial dilution; the bars show the minimum and maximum plasmid-bearing fraction at each passage. The
solid red line shows themodel fit, and the dashed red lines show the 95% confidence intervals. Each replicate was passaged once initially to allow for the cells
to acclimatize to the growth conditions. However, for the EcN-Lux:pUC-GFP-MCC replicates, most plasmid-free cells were dead after one passage so the
data from passage 0 to passage 1 were used.
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grew, indicating the presence of immune cells. Furthermore, fluorescence levels were not at the level
of the colonies grown under kanamycin selection, indicating that it is not just plasmid-bearing cells
surviving the bacteriocin. The cultures grown selectively were spotted next to bacteriocin-sensitive
EcN-Lux colonies. The first point to note is that two of the colonies grew very little, suggesting almost
complete loss of any residual plasmid-bearing cells from those cultures. Furthermore, the fluorescence
levels of all the other colonies are greater than those of the colonies grown non-selectively. This indicates
that plasmid-bearing cells, expressing GFP, are still present in these cultures but are diluted by kana-
mycin-sensitive, plasmid-free bacteria. Finally, for all but one of the colonies that grew under selective
conditions, the growth of the bacteriocin-sensitive strain spotted next to them is inhibited. This shows
that there are still bacteriocin-producing cells within those colonies. These observations together show
that the plasmid loss seen in Figure 3D for the pUC-GFP-MCC-bearing strain is due to the development
of immunity by plasmid-free bacteria (Feldgarden and Riley, 1999), not the loss of the ability to produce
bacteriocin.
axe/txe and hok/sok Successfully Stabilizes Luminescent Reporters In Vivo
Weproduced a luminescent reporter plasmid, p24-Lux, that constitutively expresses the luxCDABE operon
from the phelp promoter (Riedel et al., 2007) and cloned in the three PSK systems, so that we could visualize
its presence in vivo (Figure 5A). Plasmid stability for these luminescent plasmids was then determined using
the same protocol as for the fluorescent pUC-GFP-based strains. However, measurements could only be
carried out using population luminescence in a microplate reader rather than single-cell fluorescence in
a flow cytometer. Figure S20 shows that the control population (EcN:p24-Lux) has almost completely
stopped luminescing by the end of the first passage. The two TA strains and the microcin-V-carrying
strain perform better than the control and rank in the same order as the fluorescent plasmids. However,
the luminescence loss occurs faster and even affects the axe/txe-bearing strain.
EcN strains containing the p24-Lux-HS, p24-Lux-AT, p24-Lux-MCC, or p24-Lux control constructs were
intravenously injected into a mouse tumor model for in vivo characterization (Danino et al., 2015).
Once administered, the EcN strain was shown to colonize the tumors in the mouse flanks within
3 days (Figure 5A). The mice were visualized daily, and luminescence readings were taken to determine
the presence of protein production by our engineered bacteria within each tumor. Regions of interest
(ROIs) were manually drawn around each tumor. The average radiance across each ROI (Figure 5C) shows
the colonization and continued production of luminescence by the strains. The luminescence peaks
between 3 and 4 days after administration and then begins to decline. However, the luminescence of
tumors for mice administered with the EcN-Lux strain without plasmid, continues to increase, indicating




Figure 5. In Vivo Stability of Plasmid-Bearing EcN
(A) The plasmid stability systems were cloned into a plasmid using the constitutive help promoter to express luminescence genes.
(B) Representative image of plasmid-produced luminescence after bacterial colonization of implanted hind flank tumors.
(C) The luminescence was measured for each tumor, once a day for a week, showing colonization of the tumors by the bacterial strain and continued
production of the recombinant luminescence genes. (Black circles show outliers.)
(D) Fraction of bacterial population remaining plasmid bearing 7 days after colonization, calculated from colony counts on selective and non-selective media
performed in triplicate for each tumor. (Circles show samples, red circles are considered outliers. *p = 0.034, **p = 0.0013 in theMann-Whitney U test for p24-
Lux n = 9 tumors, p24-Lux-HS n = 7 tumors, p24-Lux-AT n = 8 tumors, p24-Lux-MCC n = 5 tumors.)
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plasmid loss.
The tumors were then excised 7 days after injection, and a colony count was performed from the homogenized
tissue to independently measure the stabilizing effect of the axe/txe, hok/sok, and microcin-V systems on the
reporter construct. Figure 5D shows that without any stabilizing system 50% of the population had dropped
the p24-Lux plasmid after intravenous injection and tumor colonization. In comparison, the p24-Lux-AT was
significantly stabilized (p = 0.0013) with nearly 100% of the population maintaining the plasmids after coloniza-
tion. The strain p24-Lux-HS also showed significant stability over p24-Lux control (p = 0.034) with 80% of theiScience--, 1–12,--, 2019 9
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significant improvement over the control, although themean plasmid-bearingpopulationwas70%. There was
also no significant difference between the plasmid-fraction-bearing population in p24-Lux-AT and p24-Lux-HS.
DISCUSSION
We developed an automated flow cytometry pipeline, mathematical model, and Bayesian inference pro-
cedure to quantify the efficacy of PSK systems stabilizing fluorescent and luminescent reporter constructs
in vitro and in vivo. We used this pipeline to demonstrate that two new PSK systems in EcN, axe/txe and
microcin-V, can outperform the more commonly used hok/sok system. Our method for Bayesian parameter
estimation is able to accurately infer parameters from simulated data, and, where plasmid loss occurs, it can
be used to estimate growth rate differences, plasmid loss rates, and PSK efficacy.
As expected, plasmids expressing fluorescent and luminescent proteins were shown to reduce the growth rate
of EcN significantly, but there was minimal extra burden produced from the TA systems and a small burden
from the bacteriocin system. Using four different plasmid origins of replication we have shown that plasmid
copy number proportionally affects the growth rate of the plasmid-bearing strain. Here we have shown that
the conventional wisdom, that lower copy number plasmids are less stable, is incorrect. Our mathematical
model demonstrates that burden is an important consideration in plasmid stability. As such, any reduction
in growth rate associated with higher copy number can prove more of a hindrance to plasmid maintenance
than the increased chance of plasmid loss due to low plasmid copy number. Future work could include the
use of whole-cell models to investigate how burden, copy number, and plasmid instability are related.
Our plasmid stability assays with both the fluorescent and luminescent plasmids showed that axe/txe pro-
vides greater plasmid stability than hok/sok. This is an interesting result as hok/sok is an E. coli-native TA
system, whereas axe/txe was found in the gram-positive E. faecium. Furthermore, hok/sok is bactericidal
(Faridani et al., 2006), whereas axe/txe is only bacteriostatic (Grady and Hayes, 2003). One might expect
that the plasmid-free persister cells created from the txe toxin would begin to divide at a later passage
and cause the plasmid-bearing population to become diluted, but this did not appear to happen during
the 37 passages of the fluorescent strains.
The results for microcin-V show far more variability in plasmid stability than those for the TA systems. We
have demonstrated that in those replicates in which plasmid loss was observed, plasmid-free cells had
developed immunity to the bacteriocin. The similarity of microcin-V to bacteriocin systems already present
in EcN 1917 may have made it simpler for such immunity to develop. However, there are a vast range of
other bacteriocins to choose from that may well prove more reliable for prolonged applications.
Although microcin-V does not perform as well as axe/txe over the length of the plasmid stability experi-
ments, we have shown that over a single passage of 24 h the bacteriocin is able to push a diluted population
back to entirely plasmid bearing. For this reason, microcins may be particularly effective in industrial
fermentation applications wherein the environment is relatively stable compared with the in vivo conditions
encountered in clinical use.
A major focus of synthetic biology over the coming years will be to push proof-of-principle systems into
real-world applications. A big limitation for industrial and clinical applications adopting synthetic biology
tools is the use of antibiotic selection, and moving away from these laboratory-based systems will be crit-
ical. Our developed experimental and modeling approach can be used to characterize new systems for in-
dustrial applications and novel therapeutics. By inferring information about the relative growth rates and
killing efficiency, a more quantitative viewpoint of plasmid stability mechanisms can be achieved, enabling
the targeting of PSK systems to specific applications.
Limitation of Study
Our study contains two main limitations, which could be addressed with further work. (1) The mathematical
model assumes constant plasmid copy number, within the plasmid-bearing population, during a passage,
and between all passages. The average plasmid copy number at different time points within a passage has
been shown to be dependent on the plasmid origin of replication (Jahn et al., 2016). It is, however,
commonly known that adaptation between plasmid and host bacteria occurs after several generations
(Bouma and Lenski, 1988) and that regulation of plasmid copy number may be involved. (2) Our modeling10 iScience--, 1–12,--, 2019
Please cite this article in press as: Fedorec et al., Two New Plasmid Post-segregational Killing Mechanisms for the Implementation of Synthetic
Gene Networks in Escherichia coli, iScience (2019), https://doi.org/10.1016/j.isci.2019.03.019also assumes no change in growth rate across passages, which due to the coevolution of plasmid and host,
is likely to be an oversimplification as fitter cells are selected.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
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1 Transparent Methods
Analytical Solutions to Plasmid Stability Models
Analytical solutions to the mathematical models in the main text were calculated using Mathematica (Wolfram
Research, Inc. n.d.). The proportion of the population that is plasmid-bearing after τ plasmid-free generations
can be written for the TA model as:









and for the bacteriocin model as:
φτ (λ, γ, ω) =
e(γ−γλ)τ




where ν = X
−(0)
X+(0) . For the plasmid loss experiments we assume that the initial population is entirely plasmid
bearing i.e. ν = 0.
Modelling Noise in Plasmid Loss Curves
The experimental method used to determine plasmid stability relies on sampling a population of cells and
classifying each one as plasmid-bearing or plasmid-free. Every one of the n cells sampled is equivalent to a
Bernoulli trial where “success” is a cell being plasmid-bearing and the probability parameter corresponds to the
proportion of plasmid-bearing cells in the culture from which the sample was drawn. As such, a hypergeometric
distribution can be used to describe the number of plasmid-bearing cells in any sample. However, since the
fraction of the total population being sampled is very small, ∼ 1/5000, a binomial model is a reasonable
approximation:
X+ ∼ Binomial(n, φ) (3)
where n is the number of cells sampled and φ is the true proportion of plasmid-bearing cells in the population
from which the sample was drawn.
The binomial model can describe the noise introduced in sampling the plasmid loss experiments but does not
incorporate any intrinsic biological noise, which will result in overdispersion of the data. The “true proportion
of plasmid-bearing cells”, φ, from which the sample was taken, is the parameter that is effected by this biological
noise. The uncertainty in this parameter is traditionally modelled using a beta distribution and the binomial
and beta model can be combined into a beta-binomial model:













thus the parameter ρ is used to reflect the uncertainty in φ. Simulated plasmid loss curves can be produced by
sampling r replicates from the beta-binomial model at t timepoints. The plasmid-bearing population fraction
is then given by:




where X+r,t are r replicate samples at t timepoints from the beta-binomial distribution in Equation 4. φ in
Equations 5 and 6, is generated at each timepoint using either the TA model in Equation 1 or the bacteriocin
model in Equation 2. The effects of the sample size, n, and the uncertainty parameter, ρ, are shown in
Supplementary Figure S22.
1
Strains and Plasmid Construction
Lysogeny broth (LB) media and agar was used during propagation and cloning of bacteria. Assays were
carried out in LB media and when antibiotic selection was applied, kanamycin was used at 25 µg/mL and
erythromycin at 100 µg/mL. All DNA manipulations were performed in E. coli DH5α (NEB) or E. coli Mach
1. All final plasmid stability assays were performed either in E. coli Nissle 1917 (EcN) or in E. coli Nissle 1917
with a genomically integrated erythromycin-resistant and luxCDABE cassette (EcN-Lux) (Danino et al. 2015)
(Table S1).




DH5α Used for cloning. New England BioLabs
Mach 1α Used for cloning. Invitrogen
EcN E. coli Nissle 1917. Prof. Ian Henderson, UK
EcN-Lux E. coli Nissle 1917 with chromosomal luxCDABE and erythromycin resistance. (Danino et al. 2015)
Plasmids
pKG1022 A plasmid carrying hok/sok from pPR633. (Gerdes 1988)
pREG531 A plasmid carrying axe/txe from pRUM. (Grady & Hayes 2003)
pHK11 A plasmid carrying microcin-V from pColV-K30. (Gilson et al. 1987)
pSEVA471 SC101 ori; SpR. (Martinez-Garcia et al. 2014)
pSEVA261 p15A ori; KanR. (Martinez-Garcia et al. 2014)
pSEVA246 Hybrid pRO1600/ColE1 ori; KanR; promoterless luxCDABE. (Martinez-Garcia et al. 2014)
pUC-GFP High copy pUC ori; KanR; 4540bp; constitutive daGFP expression under the Oxford Genetics
strong OXB20 promoter.
pUC-GFP-HS pUC-GFP with hok/sok cassette. This study
pUC-GFP-AT pUC-GFP with axe/txe cassette. This study
pUC-GFP-MCC pUC-GFP with microcin-V cassette. This study
pSC101-GFP pUC-GFP with the pUC ori replaced with SC101 from pSEVA471. This study
p15A-GFP pUC-GFP with the pUC ori replaced with p15A from pSEVA261. This study
pColE1-GFP pUC-GFP with the pUC ori replaced with hybrid pRO1600/ColE1 ori from pSEVA246. This study
pSC101-GFP-HS pSC101-GFP with with hok/sok cassette. This study
p15A-GFP-HS p15A-GFP with hok/sok cassette. This study
pColE1-GFP-HS pColE1-GFP with hok/sok cassette. This study
p24-Lux pSEVA246 with phelp promoter in front of the luxCDABE operon. This study
p24-Lux-HS p24-Lux with hok/sok cassette. This study
p24-Lux-AT p24-Lux with axe/txe cassette. This study
p24-Lux-MCC p24-Lux with microcin-V cassette. This study
Fluorescent assay plasmids were constructed using the pUC-GFP plasmid containing a pUC high copy
origin-of-replication, a kanamycin resistance cassette and a dasher GFP gene being constitutively expressed in
high quantities by the OXB20 promoter (Oxford Genetics, UK). The SC101, p15A and ColE1-RO1600 origins-
of-replication were PCR amplified from their respective SEVA plasmids using the primers P.SEVA.ORI.F and
P.PacI.SEVA.ORI.R. The fragments were digested using PacI and and FseI along with the pUC-GFP plasmid.
The digested vector gel extracted to remove the band for the pUC origin and ligated with the new origin-of-
replication fragments to create pSC101-GFP, p15A-GFP and pColE1-GFP.
Plasmid pUC-GFP-HS was created by ligating the 633bp HindIII to SacI fragment digested from pKG1022
(Gerdes 1988) into the MCS of pUC-GFP digested with the same restriction enzymes. Hok/sok was cloned
into the other copy number plasmids in the same way. Plasmid pUC-GFP-AT was created by ligating the
1390bp BamHI to SacI fragment digested from pREG531 (Grady & Hayes 2003) into the MCS of pUC-GFP
digested with the same restriction enzymes. Plasmid pUC-GFP-MCC was created by PCR amplification of
pHK11 (Gilson et al. 1987) with primers P.SacI.mccV.FOR and P.XbaI.mccV.REV to amplify the microcin-V
fragment with >400bp upstream and downstream of the annotated genes. This fragment was then digested with
XbaI and SacI and ligated into pUC-GFP which had been digested using the same restriction enzymes. These
plasmids were transformed into EcN-Lux using a standard thermal-shock transformation method to produce
EcN-Lux:pUC-GFP, EcN-Lux:pUC-GFP-HS, EcN-Lux:pUC-GFP-AT, EcN-Lux:pUC-GFP-MCC (Table S1).
Luminescent assay plasmids were constructed from pSEVA246, a plasmid based on the SEVA architecture
(Silva-Rocha et al. 2012, Martinez-Garcia et al. 2014) with a hybrid pRO1600/ColE1 high copy origin-of-
replication, a kanamycin resistance cassette, and a multiple cloning site (MCS) upstream of a promoterless
luxCDABE operon. The plasmids were produced in two steps. First the PSK systems were cloned into the MCS
of plasmid pSEVA246. The hok/sok fragment was PCR amplified from pUC-GFP-HS with primers P.HS.SacI.F
and P.HS.BamHI.R. This fragment was then digested with SacI and BamHI and ligated into pSEVA246 digested
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with the same enzymes. pUC-GFP-AT was digested with SacI and BamHI and the 1.3Kbp axe/txe fragment
was ligated into pSEVA246 digested with the same enzymes. pUC-GFP-MCC was digested with SacI, XbaI
and ApaLI; the third enzyme was added to cut the unwanted fragment and enable the gel extraction of the
4.8Kbp microcin-V fragment. This was ligated into pSEVA246 which had been digested with SacI and XbaI.
The constitutive phelp promoter (Riedel et al. 2007) was cloned upstream of the luxCDABE cassette using
Gibson assembly (Gibson et al. 2009). EcN was transformed individually with these plasmids via heat-shock
methods to produce EcN:p24-Lux, EcN:p24-Lux-HS, EcN:p24-Lux-AT, EcN:p24-Lux-MCC (Table S1).
Growth Rate Assays
For fluorescent assay plasmids, overnight cultures of each strain were grown in selective LB media for 16 hours
and diluted 1/1000 into 10 mL of non-selective LB media. 200 µL from each culture was then transferred into
6 wells of a black clear-bottom 96-well microtitre plate (Greiner Bio-one, Germany) and sealed with a Breathe-
Easy sealing membrane (Sigma-Aldrich, UK). The plate was then grown in a shaking TECAN Spark microplate
reader at 37◦C for 20 hours with OD600 readings taken every 10 minutes. Growth curves were fitted using
a non-parametric Gaussian process method (Swain et al. 2016). The same protocol was used for luminescent
assay plasmids, however, due to the instability of the control luminescent plasmid (p24-Lux), kanamycin was
added to the media for all of the plasmid-bearing strains in order to ensure the growth rates of plasmid-bearing
bacteria were being measured. The luminescent assay plasmids were all compared to liquid cultures of EcN
grown in plain LB media with no added antibiotics. The growth data and fits are shown in Supplementary
Figures S3, S12 and S24.
qPCR Experiments to Determine Plasmid Copy Number
Calibration curves
Cultures of EcN-Lux and the four pUC-GFP based strains were grown overnight in 5 mL LB media with the
appropriate antibiotics in 15 mL Falcon tubes. Cells were harvested from the overnight liquid cultures by
centrifuging at 4C for 10 min at 4000 rpm. Supernatant was removed and cell pellet resuspended in a modified
QuantiLyse buffer (10 mM Tris-HCl pH8.2, 100 µg mL−1 Proteinase K, 5 µM SDS (Pierce et al. 2002), with
the addition of 1 mg mL−1 Lysozyme and 0.5 µg mL−1 Polymyxin B; QLP), a protease-based lysis buffer to
extract DNA (genomic and plasmid) from cells. Resuspended cells were then further diluted with QLP buffer
in 1:5 serial dilutions from 1/1 (neat) to 1/3125 of original cell content, to be used to generate qPCR standard
curves. Samples were incubated at 37◦C for 30 min, 50◦C for 30 min, denatured at 95◦C for 10 min, and held
at 18◦C.
The NEB Luna Universal qPCR Master Mix kit (#M3003) was used as per protocol (20 µL reactions), with 2
µL of each serial dilution sample as template DNA. Primers YKH341 (5- CAGGAGGCTTTCGCATGATTGA-
3) and YKH342 (5- TCAGAGCAGCCGATTGTCTG-3) were used to amplify a 112bp portion of the aph(3)II
(KanR) gene on the plasmid DNA (P), whilst primers YKH343 (5-GGTCAAGTCACCACCACTGT-3) and
YKH344 (5-GCTCTTGTTCCATCTGGCGA-3) amplified a 121bp fragment spanning the terB-tus genes on
the genomic DNA (G). qPCR of the serial dilutions of plasmid and genomic DNA was carried out on the
LightCycler 480 Instrument II System, set to detect SYBR Green I (excitation at bandpass 465 nm, half
band width 24 nm; detection at bandpass 510 nm, half band width 20 nm). The programme conditions are
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separated into four stages, for initial denaturation of DNA, cycles of amplification and product/SYBR Green
quantification, melt curve analysis, and a final holding step (Table S3).
Crossing point (Cp) values (the cycle at which the amplified sample fluorescence first rises above background
fluorescence; typically when 1011 to 1012 molecules are present in the reaction; Roche Diagnostics GmbH, 2008)
generated in the quantification stage are plotted against the log10 of dilution ratio values to generate standard
curves for plasmid and genomic DNA (Supplementary Figure S25). The standard curves are used to identify an
appropriate dilution ratio for subsequent qPCRs in amplifying plasmid and genomic DNA and for calculating
PCR efficiency. PCR efficiency, E, was calculated from the gradient, m, of each standard curve with the
equation E = 10(−1/m). While a standard curve with m = −3.32 would be a perfect amplification reaction with
E = 2, often the reactions have inefficiencies. Genomic DNA amplification efficiency was 1.84, and plasmid
DNA amplification efficiency was 1.88.
The melt curve analyses generated by the LightCycler 480 Software was used to check for specificity in
product amplification. P amplicons are expected to have a melting temperature (Tm) of 85◦C, whilst G
amplicons have Tm=80◦C. qPCR products were further run on 3% agarose, 1mM lithium acetate gels to verify
the results from the melt curve analyses.
Plasmid loss confirmation
The wells of two 96-well microtitre plates were filled with 200 µL of LB media with erythromycin. In the first
plate, each of the wells was inoculated from glycerol stocks of the strains used to inoculate the initial plate
for the plasmid stability assay, producing six replicates of each strain. In the second plate, each of the wells
was inoculated from glycerol stocks made at the 30th passage of the plasmid stability assay. These plates were
sealed with Breathe-Easy sealing membranes (Diversified Biotech) and incubated at 37◦C for 16 hours with
continuous shaking.
As before, cells were harvested by centrifuging at 4◦C for 10 min at 4000 rpm, the supernatant was removed,
and the pellets were resuspended in QLP buffer. Samples were diluted down to 1/25 of original cell content,
and used as template with the NEB Luna Universal qPCR Master Mix kit (#M3003), as described previously.
Again, all qPCR products were run on 3% agarose, 1mM lithium acetate gels to verify qPCR product specificity.





where EG and EP are amplification efficiencies of the genomic and plasmid PCRs and CpG and CpP are the
crossing point values determined for each sample.
Plasmid copy number determination
Cultures of each of the strains containing the plasmids with different origins of replication were grown overnight
in 5 mL LB media with erythromycin and kanamycin in 15 mL Falcon tubes. The wells of a 96-well microtitre
plate were filled with 200 µL of LB media with erythromycin and kanamycin. Each of the wells was inoculated
with 1 µL from the overnight cultures, for a total of six replicates per strain. The plate was sealed with a
Breathe-Easy sealing membrane and incubated at 37◦C for 16 hours with continuous shaking. The plate was
then treated as above to determine average plasmid copy number for each well.
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Plasmid Stability Assays in Liquid Culture
Assays were performed in LB media in sterile deep square 96-well (2.2mL) polypropylene plate. The edge wells
were used for LB media controls so that the strains weren’t affected by any potential plate edge conditions (Hall
et al. 2013). The 96-well plate was split into two sections; one section with 500mL LB media containing ery-
thromycin (100µg/mL) and kanamycin (25 µg/mL) and the second with LB media containing only erythromycin
The erythromycin was used to prevent external contamination as the resistance gene is encoded on the chro-
mosome of the EcN-Lux bacterial strain. The kanamycin is used to ensure plasmid maintenance, generating a
plasmid-bearing control throughout the experiment.
For the plasmid stability assay with various PSK mechanisms based on the fluorescent reporter plasmid,
three double selective wells for each strain (EcN-Lux:pUC-GFP, EcN-Lux:pUC-GFP-HS, EcN-Lux:pUC-GFP-
AT, EcN-Lux:pUC-GFP-MCC) were inoculated by picking single colonies from selective LB agar plates. Six
single selective wells were inoculated with EcN-Lux, as a plasmid-free control, by picking single colonies from
selective LB agar plates. The plate was covered with a System Duetz breathable silicon sandwich (EnzyScreen,
The Netherlands) and clamped down in a shaking incubator at 37◦C and 350 rpm for 24 hours. This produced
the time point 0 cultures. These cultures were then used to inoculate 1:500 a fresh plate, arranged with the
same selective layout. Each double selective culture was used to inoculate 3 replicates for the assay of PSK
systems in single selective media. This produced 9 replicates of each plasmid-bearing strain in single selective
media and 3 in double selective media. The EcN-Lux plasmid-free control had 6 replicates in single selective
media. Although the double selective media was inoculated with the EcN-Lux strain, as expected, no bacteria
grew. This plate was covered and incubated as before. For subsequent passages the plate was replicated 1:500
into fresh media with a one-to-one mapping between wells.
At each passage, 200 µL of the overnight culture was transferred into a black clear-bottom 96-well microtitre
plate (Greiner Bio-one, Germany) and absorbance (600 nm), fluorescence (ex=480 nm, em=540 nm), and
luminescence were measured in a microplate reader. In addition, 1 µL of the overnight culture was transferred
into a round-bottom 96-well microtitre plate containing 200 µL of PBS and the single cell fluorescence was
measured using a flow cytometer.
For the plasmid stability assay with various PSK mechanisms based on the luminescent reporter plasmid,
the assay was carried out as above but the initial inoculations were with the luminescent strains (EcN:p24-Lux,
EcN:p24-Lux-HS, EcN:p24-Lux-AT, EcN:p24-Lux-MCC) and the plasmid free control was EcN rather than
EcN-Lux. Furthermore, the assays could not be performed with erythromycin as the EcN bacterial host did not
contain the resistance gene. In order to prevent external contamination in LB cultures without any antibiotic,
the entire plate was additionally exposed to UV light for 40 minutes before inoculation at each passage (Sharma
2012). Further, only absorbance and luminescence could be measured so the preparation of the plate for flow
cytometry was not carried out. Absorbance was additionally measured at 410nm.
For the plasmid stability assay with various origins-of-replication, the assay was performed as with the
fluorescent PSK plasmids. The initial inoculations were with strains EcN-Lux:pUC-GFP, EcN-Lux:pUC-GFP-
HS, EcN-Lux:pSC101-GFP, EcN-Lux:pSC101-GFP-HS, EcN-Lux:p15A-GFP, EcN-Lux:p15A-GFP-HS, EcN-
Lux:pColE1-GFP, EcN-Lux:pColE1-GFP-HS into double selective media and the plasmid free control was EcN-
Lux. Due to the larger number of strains, each double selective culture was used to inoculate 2 replicates rather
than 3.
Flow Cytometry Data Processing
In order to ensure the capture of all bacterial events during flow cytometry sampling, a threshold was used
that also captured a considerable amount of non-bacterial events. This can be problematic as the small size of
bacteria leads to the bacterial population appearing very close to this debris. A further problem is that more
than one bacterium can be read as a single event due to clumping. A computational pipeline was developed to
automate the gating of singlet bacteria while excluding background debris and bacterial doublets. This process
is important to automate as it removes operator bias associated with the manual drawing of gates and speeds
up the analysis when large numbers of samples are recorded.
The method fits two dimensional mixture models of one and two clusters to the forward-scatter-height and
side-scatter-height variables with 95% confidence. Using integrated completed likelihood (ICL) (Biernacki et al.
2000) the number of clusters that best fits the data is determined. This allows for compatibility with experiments
in which debris has been removed by hand by an experimenter or if not many debris events are recorded. For
any clusters found, their median positions are determined and if a cluster is below a pre-determined threshold
it is considered debris and removed.
Doublets are then removed in one of two ways. Initially, a linear model was fitted to the side-scatter-height
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versus side-scatter-area data and points falling too far away were removed as doublets. An update to the Attune
NxT software implemented area scaling which is calibrated automatically during the start-up procedure. The
area scaling allows the assumption that singlets will lie on, or close to, the line side-scatter-height = side-scatter-
area. As such, for later experiments this method is used for doublet discrimination.
The output from this processing are standard flow cytometry .fcs files with debris and doublets removed.
The software, written in R, for performing this analysis can be found at https://github.com/ucl-cssb/autoGate.
Hierarchical Bayesian Model Fitting to Plasmid Loss Curves
The models detailed by Equations 1 and 2 are fitted to the experimental plasmid loss curves using a hierarchical
Bayesian model.
From the plasmid loss experiments, at each timepoint, t, there are r replicates for which analysis of the flow
cytometry data produces the number of plasmid-bearing cells X+r,t in a sample of size nr,t. Note that the sample
size varies for each sample as all cells within a specified volume are measured rather than cutting off after a
given number of events have been recorded.
The aim here is to determine the set of model parameters, {λ, γ, ω}, and noise parameter, ρ, which are
most likely to produce the data observed using flow cytometry. To do so we build a hierarchical model for the
three plasmid loss model parameters, Supplementary Figure S23. In this model, the log of the plasmid loss
probability, λ, has a global distribution for all strains with plasmids based on the same backbone. The posterior
distribution for this global λ is determined by sampling from a uniform prior, U(−10, 0) and the posterior
distribution for the standard deviation, σλ, in the global λ is sampled from an exponential prior, Exp(100),
which produces a shrinkage pressure on the distribution. Below the global level, there is a distribution on λ for
each strain, sampled from a normal distribution with a mean sampled from the global distribution on λ and a
standard deviation sampled from the global distribution on σλ. There is a strain level standard deviation on
the strain level λ which is sampled from an exponential prior in the same manner as the global one. Finally,
at the lowest level, each replicate of a strain has a posterior distribution on λ which is sampled from a normal
distribution with mean sampled from the strain level λ and standard deviation sampled from the strain level
standard deviation.
Since the growth rates of each strain can be directly measured, strain level distributions for the growth ratio
parameter, γ, can be directly determined. As such, the replicate level posterior distributions for γ are sampled
from a normal distribution with mean sampled from the strain level γ and standard deviation given by the
standard deviation of the strain level γ.
The parameter encapsulating the efficacy of the killing mechanisms, ω, cannot be said to be globally linked.
This is particularly true when considering the differences between the bacteriocin and TA systems but also
applies between different TA systems as they function in distinct ways. As such, each strain has a posterior
distribution on ω and standard deviation sampled from uniform priors. Each replicate then has a posterior
distribution on ω sampled from a normal distribution with mean and standard deviation sampled from the the
strain level ω and standard deviation.
The fitting is performed for all data for all strains concurrently using Rstan, the R language version of stan










where θ is the full set of parameters, {λs,r, λs, σλs , λ, σλ, γs,r, γs, σγs , ωs,r, ωs, σωs , ρs,r} and:
P (X+s,r,t|θ) = Beta-Binomial (ns,r,t, αs,r,t, βs,r,t)







αs,r,t − αs,r,t φs,r,t (λs,r, γs,r, ωs,r)
φs,r,t (λs,r, γs,r, ωs,r)
This hierarchical method of fitting can be demonstrated using simulated data of two strains, with and
without PSK. Both of these data sets are simulated using the same plasmid loss probability, λ, growth rate
ratio, γ, and noise, ρ. The difference is in the PSK efficacy parameter, ω. Supplementary Figure S2 shows the
model fit to the full set of timecourses for each simulated strain, using the strain level parameter posteriors.
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Plasmid-bearing Strain Dilution Assays
Starter cultures were produced in the same way as for the plasmid stability assays. Different dilutions of
plasmid-bearing to plasmid-free strains were then produced by pipetting different volumes of plasmid-bearing
overnight culture into EcN-Lux overnight culture in percentages from 10% through to 100%, keeping a total
volume of 100 µL. For example, to produce a 30% culture 30 µL of plasmid-bearing overnight culture was added
to 70 µL of EcN-Lux overnight culture. Note that the overnight cultures were not normalised to the same optical
density, so a 30% culture does not mean that 30% of the cells are plasmid-bearing. Assays were performed in
LB media in sterile autoclaved deep square 96-well (2.2mL) polypropylene plate. Each well was filled with 500
µL of LB media with erythromycin (100 µg/mL). The wells were then inoculated in a random pattern with 3
replicates of each of the diluted cultures. At the same time a 96-well mictrotitre plate was prepared with 200 µL
of PBS in each well and inoculated from the same diluted cultures and measured using the same flow cytometry
set up as above. The deep well plate was then sealed and incubated as above. After 24 hours the plate was
taken from the incubator and passaged while a flow cytometry plate was also prepared and measured. This was
carried out for a total of 2 passages. We used the data from passage 1-2 for the model fitting as this allowed
the cells time to get used to growing in the deep-well plate. However, for the MCC strain we had to use data
for passage 0-1 because after 24 hours all plasmid-free bacteria had been killed.
Luminescent Plasmid Stability Assays in vivo
All animal work was approved by the institutional committee on animal care (Columbia, AC-AAAN8002). The
protocol requires animals to be euthanized when tumours reach 2 cm3, or under veterinary staff recommenda-
tion. The cell line (MC26-LucF, Tanabe laboratory, Massachusetts General Hospital) was obtained from, and
authenticated by, the Tanabe laboratory, MGH. The cell line was tested to be mycoplasma-free before implan-
tation in mice. Sample sizes for mice were determined by expected effect size to produce a power of 0.8-0.9.
Mice were blindly randomized into various groups using a random number generator.
Animal experiments were performed on 6-week-old female BALB/c mice (Taconic Biosciences) with bilateral
subcutaneous hind flank tumours from an implanted mouse colon cancer cell line (MC26-LucF). The concen-
tration for implantation of the tumour cells was 108 cells per ml in DMEM (no phenol red). Cells were then
implanted subcutaneously at a volume of 100 µL per flank, with each implant consisting of 107 cells. The
MC26 cells where given 14 days to graft and grow until they reached a size of approximately 150-200 mm3.
Along with an EcN-Lux strain as a control, EcN:p24-Lux, EcN:p24-Lux-HS, EcN:p24-Lux-AT and EcN:p24-
Lux-MCC were grown up in LB with kanamycin until exponential phase, washed three times in sterile PBS and
then injected intravenously at a dosage of 1x106 bacteria in 100 µL. After bacterial colonisation of the tumours,
animals were monitored via IVIS (IVIS 200, Caliper Life Sciences) to detect the presence of the plasmid via
bioluminescence. Briefly, this involved anaesthetising the mice with isoflurane and imaging with an open filter
on the auto-exposure setting. After 7 days, each of the tumours were sterilely extracted and homogenised using
a tissue dissociator (Miltenyi), an aliquot of which was seeded on each of LB plates and LB with kanamycin
plates. The ratio was calculated by comparing the mean counts of plasmid bearing colonies on LB plates and
LB plates with kanamycin from each tumour (Danino et al. 2015). ggplot2 package in R was used for plotting.
Statistical significance was demonstrated by the Mann-Whitney U test with R.
Bacteriocin Resistance Check
The wells of a 96-well microtitre plate was filled with 200 µL of LB media, half with erythromycin and half with
erythromycin and kanamycin. The wells of this plate were inoculated with 1 µL of each of the EcN-Lux:pUC-
GFP-MCC wells from a glycerol stock of the 30th passage of the plasmid loss experiment, replicated so that
there was a sample of each well growing under each selective condition. Additionally, wells of EcN-Lux and a
control EcN-Lux:pUC-GFP-MCC were inoculated under each selective condition. This plate was then sealed
with a Breathe-Easy membrane and grown at 37 ◦C in a shaking plate reader for 6 hours. 1 µL from each of
the wells was then spotted onto an LB agar plate, also containing erythromycin. Next to each of the cultures
grown in LB+Er was spotted 1 µL of the control EcN-Lux:pUC-GFP-MCC, grown in LB+Er. Next to each
of the cultures grown in LB+Er+Kn was spotted 1 µL of EcN-Lux grown in LB+Er. The left to dry until
the spots were no longer visibly wet. The plate was then placed in an incubator at 37 ◦C fro 16 hours. After
incubation, images of the plate were taken on a blue light transilluminator with amber filter (IORodeo), to
record GFP fluorescence, and using a gel documentation system with UV transillumination, to visualise colony










































































Figure S1: related to Figures 3 and 4. Effects of model parameters on plasmid-loss curves.
A) Varying the plasmid loss probability, λ, and B) the doubling time ratio, γ, without post-
segregational killing or bacteriocin killing. These are identical for the TA and the bacteriocin
models when ω = 0. C) Varying the efficacy of the toxin, ω, in the TA model. D) Varying the


















































































Figure S2: related to Figure 3. Fits of the hierarchical model at the strain level to simulated
plasmid loss curves A) without PSK and B) with PSK. The grey lines show the nine simulated
trajectories, the solid red line shows the mean model fit and the dashed lines show the 95%
confidence intervals. Since the ω parameter is not relevant to the fitting of the timecourses
without PSK, the posterior distribution of the noise parameter ρ is shown below the plasmid loss
curve of (A) instead.
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Figure S3: related to Figure 2. Growth curves and model fits for the fluorescent plasmids with
different origins-of-replication in EcN-Lux grown in LB media with erythromycin. (A) Logged
optical density measured at 600nm. The points show 6 replicates for each strain with the different
colours indicating each replicate. The blue line shows the non-parametric Gaussian process fit
with standard error shown by the light blue area around the line. (B) Estimated growth rate as
a function of time. (C) Estimated maximal growth rates and (D) estimated lag time. The red
lines show the standard deviation of the mean.
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Figure S4: related to Figure 2. Flow cytometry samples of EcN-Lux:pSC101-GFP. A) 3 replicates
grown in LB media with erythromycin and kanamycin, ensuring plasmid maintenance. The black
dashed line indicates the median fluorescence at passage 0. B) 6 replicates grown in LB media
with erythromycin only, allowing for plasmid loss.
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Figure S5: related to Figure 2. Flow cytometry samples of EcN-Lux:p15A-GFP. A) 3 replicates
grown in LB media with erythromycin and kanamycin, ensuring plasmid maintenance. The black
dashed line indicates the median fluorescence at passage 0. B) 6 replicates grown in LB media
with erythromycin only, allowing for plasmid loss.
12
Figure S6: related to Figure 2. Flow cytometry samples of EcN-Lux:ColE1-GFP. A) 3 replicates
grown in LB media with erythromycin and kanamycin, ensuring plasmid maintenance. The black
dashed line indicates the median fluorescence at passage 0. B) 6 replicates grown in LB media
with erythromycin only, allowing for plasmid loss.
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Figure S7: related to Figure 2. Flow cytometry samples of EcN-Lux:pUC-GFP. A) 3 replicates
grown in LB media with erythromycin and kanamycin, ensuring plasmid maintenance. The black
dashed line indicates the median fluorescence at passage 0. B) 6 replicates grown in LB media
with erythromycin only, allowing for plasmid loss.
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Figure S8: related to Figure 2. Flow cytometry samples of EcN-Lux:pSC101-GFP-HS. A) 3
replicates grown in LB media with erythromycin and kanamycin, ensuring plasmid maintenance.
The black dashed line indicates the median fluorescence at passage 0. B) 6 replicates grown in
LB media with erythromycin only, allowing for plasmid loss.
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Figure S9: related to Figure 2. Flow cytometry samples of EcN-Lux:p15A-GFP-HS. A) 3 repli-
cates grown in LB media with erythromycin and kanamycin, ensuring plasmid maintenance. The
black dashed line indicates the median fluorescence at passage 0. B) 6 replicates grown in LB
media with erythromycin only, allowing for plasmid loss.
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Figure S10: related to Figure 2. Flow cytometry samples of EcN-Lux:ColE1-GFP-HS. A) 3
replicates grown in LB media with erythromycin and kanamycin, ensuring plasmid maintenance.
The black dashed line indicates the median fluorescence at passage 0. B) 6 replicates grown in
LB media with erythromycin only, allowing for plasmid loss.
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Figure S11: related to Figure 2. Flow cytometry samples of EcN-Lux:pUC-GFP-HS. A) 3 repli-
cates grown in LB media with erythromycin and kanamycin, ensuring plasmid maintenance. The
black dashed line indicates the median fluorescence at passage 0. B) 6 replicates grown in LB
media with erythromycin only, allowing for plasmid loss.
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Figure S12: related to Figure 3. Growth curves and model fits for the fluorescent plasmids with
different PSK systems in EcN-Lux grown in LB media with erythromycin. (A) Logged optical
density measured at 600nm. The points show 6 replicates for each strain with the different
colours indicating each replicate. The blue line shows the non-parametric Gaussian process fit
with standard error shown by the light blue area around the line. (B) Estimated growth rate as
a function of time. (C) Estimated maximal growth rates and (D) estimated lag time. The red








































Figure S13: related to Figure 3. Flow cytometry samples of EcN-Lux:pUC-GFP. A) 3 replicates
grown in LB media with erythromycin and kanamycin, ensuring plasmid maintenance. The black
dashed line indicates the median fluorescence at passage 0. B) 9 replicates grown in LB media
with erythromycin only, allowing for plasmid loss.
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Figure S14: related to Figure 3. Flow cytometry samples of EcN-Lux:pUC-GFP-HS. A) 3 repli-
cates grown in LB media with erythromycin and kanamycin, ensuring plasmid maintenance. The
black dashed line indicates the median fluorescence at passage 0. B) 9 replicates grown in LB
media with erythromycin only, allowing for plasmid loss.
21
Figure S15: related to Figure 3. Flow cytometry samples of EcN-Lux:pUC-GFP-AT. A) 3 repli-
cates grown in LB media with erythromycin and kanamycin, ensuring plasmid maintenance. The
black dashed line indicates the median fluorescence at passage 0. B) 9 replicates grown in LB
media with erythromycin only, allowing for plasmid loss.
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Figure S16: related to Figure 3. Flow cytometry samples of EcN-Lux:pUC-GFP-MCC. A) 3
replicates grown in LB media with erythromycin and kanamycin, ensuring plasmid maintenance.
The black dashed line indicates the median fluorescence at passage 0. B) 9 replicates grown in







































LB + Kn + Er
Figure S17: related to Figure 3. GFP fluorescence measurements throughout fluorescent plas-
mid loss experiment. The black lines (3 replicates) show the trajectories of strains passaged in
LB media with erythromycin and kanamycin to ensure plasmid maintenance. The red lines (9
replicates for plasmid-bearing strains and 6 replicates for EcN-Lux control) show the trajectories
in LB media with erythromycin but without kanamycin, allowing for plasmid loss. The data is
normalised by negating the mean fluorescence of the EcN-Lux in LB+Er (plasmid-free control)














































































































































































































































































Figure S18: related to Figure 3. Posterior distributions of the model parameters produced from
fitting to the plasmid loss curves. EcN-Lux:pUC-GFP has no posterior distribution for ω as it
does not carry a PSK system.
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Figure S19: related to Figure 3. Test of bacteriocin production and immunity in EcN-Lux:pUC-
GFP-MCC cultures after 30 days of passaged growth. Cultures from the 30th passage of the
plasmid loss experiment were grown in LB+Er and LB+Er+Kn and then spotted onto LB+Er
agar. The colonies grown in LB+Er were spotted next to a bacteriocin producing colony of
EcN-Lux:pUC-GFP-MCC. All of the colonies grow, indicating immunity to the bacteriocin. The
negative control, EcN-Lux, shows severely impaired growth. The cultures grown in LB+Er+Kn
were spotted next to a bacteriocin sensitive colony, EcN-Lux. Two of the colonies (E3 and E7)
show very minimal growth, indicating very limited numbers of plasmid-bearing cells remaining
in the source culture. The other colonies show normal growth and increased fluorescence, in-
dicating that the plasmid-bearing cells are still GFP expressing and are being selected for by
the kanamycin. All but three of the bacteriocin sensitive colonies show impaired growth. This
demonstrates that the plasmid-bearing cells in the source cultures are still producing bacteriocin.
26
Table S4: related to Figure 3. Summary of results from Figure S19.



















passaged in LB + Er
LB + Er 9/9 0/9 3/9
LB + Er + Kn 7/9 6/9 7/9
EcN-Lux:pUC-GFP-MCC
passaged in LB + Er + Kn
LB + Er 3/3 0/3 3/3
LB + Er + Kn 3/3 3/3 3/3
EcN-Lux -ve control
LB + Er 0/1 0/1 0/1
LB + Er + Kn 0/1 0/1 0/1
EcN-Lux:pUC-GFP-MCC
+ve control
LB + Er 1/1 0/1 1/1
LB + Er + Kn 1/1 1/1 1/1
EcN:p24−Lux−MCC EcN
EcN:p24−Lux EcN:p24−Lux−HS EcN:p24−Lux−AT































Figure S20: related to Figure 5. Luminescence measurements throughout luminescent plasmid
loss experiment. The black lines (3 replicates) show the trajectories of strains passaged in LB
media with kanamycin to ensure plasmid maintenance. The red lines (9 replicates for plasmid-
bearing strains and 6 replicates for EcN control) show the trajectories in LB media but without
kanamycin, allowing for plasmid loss. The data is normalised by negating the mean luminescence
of the EcN in LB (plasmid-free control) at each passage and scaling so that the lowest recorded
measurement is equal to 0.
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AB
Figure S21: related to Figures 3-5. Upstream regions of microcin-V with -35, -10 and transcrip-
tion factor recognition sites annotated using BPROM (http://www.softberry.com) A) The region
upstream of the cvaA and cvaB genes. Additional annotations of fur recognition sites, putative
RBS and two potential start codons from Boyer & Tai 1998. B) The region upstream of the
cvi and cvaC genes with additional fur from Boyer & Tai 1998. Note that there is a putative

















λ = 1E−05, γ = 0.8, ω = 0.9, ρ = 0.01
0.1 0.5 0.9
1e−04 0.001 0.01


















Figure S22: related to Figures 3 and 4. Effects of noise parameters on plasmid-loss curve sim-
ulated with the TA model. Nine replicates for each plasmid-loss curve. Varying a) sample size,
N, and b) the uncertainty parameter, ρ.
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log10 λ ~ U(-10,0), σλ ~ Exp(100)global
strain
replicate
log10 λ1 ~ N(log10 λ, σλ), σλ1 ~ Exp(100)
log λ1,1~ N(log λ1,σλ1) ... log λ1,r~ N(log λ1,σλ1)














ω1 ~ U(0,1), σω1 ~ U(0,0.1)
ω1,1 ~ N(ω1,σω1) ... ω1,r ~ N(ω1,σω1) 
ωs ~ U(0,1), σωs ~ U(0,0.1)...
...
log λs,1~ N(log λs,σλs) ... log λs,r~ N(log λs,σλs)
γs,1 ~ N(γs,σγs) ... γs,r ~ N(γs,σγs) 
ωs,1 ~ N(ωs,σωs) ... ωs,r ~ N(ωs,σωs) 
Figure S23: related to Figures 3 and 4. Hierarchical model for fitting parameters of the plasmid
loss models to plasmid loss data.
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Figure S24: related to Figure 5. Growth curves and model fits for the luminescent plasmids in
EcN grown in LB media. For the plasmid bearing strains the media also contained kanamycin to
ensure plasmid maintenance. (A) Logged optical density measured at 600nm. The points show 6
replicates for each strain with the different colours indicating each replicate. The blue line shows
the non-parametric Gaussian process fit with standard error shown by the light blue area around
the line. (B) Estimated growth rate as a function of time. (C) Estimated maximal growth rates
and (D) estimated lag time. The red lines show the standard deviation of the mean.
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y = 11.2 + −3.78 ⋅ x,  r2 = 0.982
y = 4.86 + −3.64 ⋅ x,  r2 = 0.984
G P







Figure S25: related to Figures 2 and 3. Calibration curves for genomic and plasmid DNA
amplification with linear fit (red line).
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